Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025
Talphera (Nasdaq: TLPH), a specialty pharmaceutical company, will release its Q2 2025 financial results on Thursday, August 14, 2025 after market close. The company will host a conference call and webcast at 4:30 PM ET/1:30 PM PT to discuss the results and provide a business update.
Investors can access the webcast through Talphera's website investor section, which will include a slide presentation. A replay will be available for 90 days. For those joining by phone, North American callers can dial 1-800-836-8184, while international callers should use 1-646-357-8785 with conference ID 32530.
[]Talphera (Nasdaq: TLPH), un'azienda farmaceutica specializzata, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 giovedì 14 agosto 2025 dopo la chiusura dei mercati. La società terrà una conference call e una webcast alle 16:30 ET/13:30 PT per discutere i risultati e fornire un aggiornamento aziendale.
Gli investitori potranno accedere alla webcast tramite la sezione investitori del sito web di Talphera, che includerà anche una presentazione con slide. La registrazione sarà disponibile per 90 giorni. Per chi partecipa telefonicamente, i chiamanti dal Nord America possono comporre il numero 1-800-836-8184, mentre i chiamanti internazionali dovranno utilizzare il numero 1-646-357-8785 con ID conferenza 32530.
Talphera (Nasdaq: TLPH), una empresa farmacéutica especializada, publicará sus resultados financieros del segundo trimestre de 2025 el jueves 14 de agosto de 2025 después del cierre del mercado. La compañía realizará una llamada conferencia y una transmisión en vivo a las 4:30 PM ET/1:30 PM PT para discutir los resultados y ofrecer una actualización empresarial.
Los inversores podrán acceder a la transmisión en vivo a través de la sección de inversores del sitio web de Talphera, que incluirá una presentación con diapositivas. La repetición estará disponible durante 90 días. Para quienes se unan por teléfono, los llamantes de Norteamérica pueden marcar el 1-800-836-8184, mientras que los llamantes internacionales deben usar el 1-646-357-8785 con ID de conferencia 32530.
Talphera (나스닥: TLPH)는 전문 제약 회사로서 2025년 2분기 재무 실적을 2025년 8월 14일 목요일 장 마감 후 발표할 예정입니다. 회사는 동부 시간 오후 4시 30분/태평양 시간 오후 1시 30분에 컨퍼런스 콜과 웹캐스트를 개최하여 실적을 논의하고 사업 현황을 업데이트할 것입니다.
투자자들은 Talphera 웹사이트 투자자 섹션을 통해 웹캐스트에 접속할 수 있으며, 슬라이드 프레젠테이션도 포함됩니다. 재방송은 90일간 제공됩니다. 전화 참여 시 북미 지역 전화번호는 1-800-836-8184이며, 국제 전화는 1-646-357-8785를 사용하고 컨퍼런스 ID 32530를 입력하면 됩니다.
Talphera (Nasdaq : TLPH), une société pharmaceutique spécialisée, publiera ses résultats financiers du deuxième trimestre 2025 le jeudi 14 août 2025 après la clôture des marchés. La société organisera une conférence téléphonique et un webcast à 16h30 ET / 13h30 PT pour discuter des résultats et fournir une mise à jour commerciale.
Les investisseurs pourront accéder au webcast via la section investisseurs du site web de Talphera, qui comprendra une présentation en diapositives. Une rediffusion sera disponible pendant 90 jours. Pour ceux qui participent par téléphone, les appelants nord-américains peuvent composer le 1-800-836-8184, tandis que les appelants internationaux doivent utiliser le 1-646-357-8785 avec l’identifiant de conférence 32530.
Talphera (Nasdaq: TLPH), ein spezialisiertes Pharmaunternehmen, wird seine Finanzergebnisse für das zweite Quartal 2025 am Donnerstag, den 14. August 2025 nach Börsenschluss veröffentlichen. Das Unternehmen wird um 16:30 Uhr ET/13:30 Uhr PT eine Telefonkonferenz und ein Webcast veranstalten, um die Ergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Investoren können über den Investor-Bereich auf der Talphera-Website auf das Webcast zugreifen, welches eine Präsentation mit Folien enthalten wird. Eine Aufzeichnung wird für 90 Tage verfügbar sein. Für Telefonteilnehmer aus Nordamerika steht die Nummer 1-800-836-8184 zur Verfügung, internationale Anrufer wählen bitte 1-646-357-8785 mit der Konferenz-ID 32530.
- None.
- None.
Webcast Information
The webcast can be accessed here or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.
Conference Call Information
Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA).
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-second-quarter-financial-results-and-corporate-update-call-and-webcast-on-thursday-august-14-2025-302524765.html
SOURCE Talphera, Inc.
FAQ
When will Talphera (TLPH) report Q2 2025 earnings?
How can investors access Talphera's Q2 2025 earnings call?
Where can I find Talphera's Q2 2025 earnings presentation slides?
How long will Talphera's Q2 2025 earnings call replay be available?
